Molecular detection of novel coronaviruses
AssigneeThe University of Hong Kong
InventorsLeo LM Poon, Malik Peiris, Daniel K.W. Chu
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Hong Kong
InventorsLeo LM Poon, Malik Peiris, Daniel K.W. Chu
Estimating the term…
Systems for sensitive and accurate detection of sarbecoviruses in samples from human sputum have been established. The systems can rapidly and effectively diagnose patients having suspected coronavirus infections. The systems employ Reverse-Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) to identify and quantify nucleic acids specific to sarbecoviruses within samples from human patients. The systems identify viral RNAs specific for the N and ORF1 genes using a two-step real-time PCR and the SYBR Green detection method. Compositions and methods for reproducibly detecting and quantifying concentrations of sarbecoviruses with a dynamic range of at least seven orders of magnitude (2×10−4-2000 TCID50/reaction) are described. The compositions and methods enable rapid early diagnosis of patients, as well as development of databases of patient viral titres and infectious dosages.
A composition for the detection of SARS-CoV-2 virus N gene comprising PCR primers for amplifying a segment of the SARS-CoV-2 virus N gene comprising nucleotides corresponding to nucleotides 905-923, 894-962, or 872-981 of SEQ ID NO:8.
A composition for the detection of SARS-COV-2 virus ORF1b gene comprising PCR primers for amplifying a segment of the SARS-COV-2 virus ORF1b gene comprising nucleotides corresponding to nucleotides 18547-18565, 18536-18604, or 18514-18645 of SEQ ID NO:7.
Dependencies are inferred from the claim text.